An Observational Study of the Administration of Eovist/Primovist in Pediatric Subjects (> 2 Months and Less Than 18 Years) Who Are Referred for a Routine Contrast Enhanced Liver MRI Because of Suspected or Known Focal Liver Lesions

Inclusion Criteria:

- Age >2 months and <18 years of age at the time of the Primovist/Eovist enhanced MRI

- MRI with Primovist/Eovist due to suspected or known focal liver lesions

- Evaluable safety data

- Evaluable efficacy data: precontrast and postcontrast magnetic resonance (MR) images
must be available for review

- If the above criteria are met, the principal investigator (PI) and/or designee will
obtain a signed consent for medical records release including access to anonymized
electronic copies of the pre- and post-Primovist/Eovist MRI scans, in accordance with
local regulatory requirements in order for subjects to be enrolled in the study.

Exclusion Criteria:

- A subject will be excluded from this observational / retrospective study if the
subject has previously been enrolled into this study. Subjects may only be entered
once into this study, even if they have been imaged multiple times and for different
indications.